Clinical Trial Update: A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for RO5095932 in Type 2 diabetes mellitus. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO5095932

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED